Polymeric delivery formulations of leuprolide with improved efficacy

Details for Australian Patent Application No. 2001292931 (hide)

Owner QLT USA, Inc.

Inventors Garrett, John S.; Chandrashekar, Bhagya L.; Dunn, Richard L.; Ravivarapu, Harish

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001292931

PCT Pub. Number WO02/30393

Priority 09711758 13.11.00 US; 09666174 21.09.00 US

Filing date 21 September 2001

Wipo publication date 22 April 2002

Acceptance publication date 24 August 2006

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/09 (2006.01) Medicinal preparations containing peptides

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

16 March 2006 Assignment before Grant

  Atrix Laboratories, Inc. The application has been assigned to QLT USA, Inc.

24 August 2006 Application Accepted

  Published as AU-B-2001292931

21 December 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001292932

2001292930